EDGAR Verified
Primary Source · SEC.gov

Rapha Capital PE Life Sciences Fund VI, LP

CIK 0001949239Fund Vehicle2023 vintage506(b)

Raised

$1M

Investors

2

Min Invest

$250,000

AltStreet Analysis

·

Generated from EDGAR primary sources

Rapha Capital PE Life Sciences Fund VI, LP is a Delaware limited partnership that filed an original Form D on 2023-02-08 under Rule 506(b). The fund raised $1.1M from 2 investors with a $250K minimum investment. Related persons include Kevin Slawin (Executive Officer, Promoter), Rapha Capital PE Life Sciences Fund GP, LLC (Promoter), and Rapha Capital Management, LLC (Promoter).

This is a private equity life sciences fund operating under the standard 506(b) exemption, which permits general solicitation restrictions. The $250K minimum investment positions it in the lower tier for institutional alternative investments, though the early-stage capital raise of $1.1M suggests an initial close or emerging fund launch.

Data Flags

total_amount_soldFirst close of $1.1M from 2 investors represents $550K average check size, more than double the $250K stated minimum; suggests either accredited individual investors or early institutional commitments
first_sale_dateFirst sale date not disclosed on original filing with active capital raise

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001949239
Entity NameRapha Capital PE Life Sciences Fund VI, LP
Exemption506(b)
First Sale Date
Filing DateFebruary 8, 2023
Accession Number0001963709-23-000004
Total Amount Sold$1M
Total Investors2
Minimum Investment$250,000
Securities TypeEquity
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Kevin Slawin

Executive Officer, Promoter · Surfside, FL

n/a Rapha Capital PE Life Sciences Fund GP, LLC

Promoter · Surfside, FL

n/a Rapha Capital Management, LLC

Promoter · Surfside, FL

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.